BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 34489848)

  • 1. Update in Autoimmune Movement Disorders: Newly Described Antigen Targets in Autoimmune and Paraneoplastic Cerebellar Ataxia.
    Garza M; Piquet AL
    Front Neurol; 2021; 12():683048. PubMed ID: 34489848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune Vestibulocerebellar Syndromes.
    Narayan RN; McKeon A; Fife TD
    Semin Neurol; 2020 Feb; 40(1):97-115. PubMed ID: 31958862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIM9 and TRIM67 Are New Targets in Paraneoplastic Cerebellar Degeneration.
    Do LD; Gupton SL; Tanji K; Bastien J; Brugière S; Couté Y; Quadrio I; Rogemond V; Fabien N; Desestret V; Honnorat J
    Cerebellum; 2019 Apr; 18(2):245-254. PubMed ID: 30350014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook.
    Jarius S; Wildemann B
    J Neuroinflammation; 2015 Sep; 12():168. PubMed ID: 26377319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'Medusa-head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj/ITPR1 and anti-CARP VIII.
    Jarius S; Wildemann B
    J Neuroinflammation; 2015 Sep; 12():166. PubMed ID: 26377085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responses to and Outcomes of Treatment of Autoimmune Cerebellar Ataxia in Adults.
    Jones AL; Flanagan EP; Pittock SJ; Mandrekar JN; Eggers SD; Ahlskog JE; McKeon A
    JAMA Neurol; 2015 Nov; 72(11):1304-12. PubMed ID: 26414229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inositol 1,4,5-trisphosphate receptor type 1 autoantibody (ITPR1-IgG/anti-Sj)-associated autoimmune cerebellar ataxia, encephalitis and peripheral neuropathy: review of the literature.
    Jarius S; Bräuninger S; Chung HY; Geis C; Haas J; Komorowski L; Wildemann B; Roth C
    J Neuroinflammation; 2022 Jul; 19(1):196. PubMed ID: 35907972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurochondrin Antibody Serum Positivity in Three Cases of Autoimmune Cerebellar Ataxia.
    Weihua Z; Haitao R; Fang F; Xunzhe Y; Jing W; Hongzhi G
    Cerebellum; 2019 Dec; 18(6):1137-1142. PubMed ID: 31179511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune movement disorders with neuronal antibodies - an update.
    Balint B; Bhatia KP
    Curr Opin Neurol; 2021 Aug; 34(4):565-571. PubMed ID: 34010219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca/ARHGAP26 and anti-VGCC.
    Jarius S; Wildemann B
    J Neuroinflammation; 2015 Sep; 12():167. PubMed ID: 26377184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Discovery of Anti-Yo (Anti-PCA1) Antibody in Patients with Paraneoplastic Cerebellar Degeneration: Opening a Window into Autoimmune Neurological Disease.
    Greenlee JE; Brashear HR
    Cerebellum; 2023 Aug; 22(4):531-533. PubMed ID: 35881322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune central nervous system paraneoplastic disorders: mechanisms, diagnosis, and therapeutic options.
    Dropcho EJ
    Ann Neurol; 1995 May; 37 Suppl 1():S102-13. PubMed ID: 8968221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraneoplastic cerebellar ataxia and antibodies to metabotropic glutamate receptor 2.
    Ruiz-García R; Martínez-Hernández E; Joubert B; Petit-Pedrol M; Pajarón-Boix E; Fernández V; Salais L; Del Pozo M; Armangué T; Sabater L; Dalmau J; Graus F
    Neurol Neuroimmunol Neuroinflamm; 2020 Mar; 7(2):. PubMed ID: 31826987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebellar ataxia and myeloradiculopathy associated with AP3B2 antibody: a case report and literature review.
    Mange L; Haitao R; Lixin Z; Siyuan F; Jing W; Hongzhi G
    J Neurol; 2021 Nov; 268(11):4163-4169. PubMed ID: 33988764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Homer-3 antibodies in cerebrospinal fluid and serum samples from a 58-year-old woman with subacute cerebellar degeneration and diffuse breast adenocarcinoma.
    Klötzsch C; Böhmert M; Hermann R; Teegen B; Rentzsch K; Till A
    Neurol Res Pract; 2022 Jul; 4(1):29. PubMed ID: 35871640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.
    Shams'ili S; Grefkens J; de Leeuw B; van den Bent M; Hooijkaas H; van der Holt B; Vecht C; Sillevis Smitt P
    Brain; 2003 Jun; 126(Pt 6):1409-18. PubMed ID: 12764061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Septin-3 autoimmunity in patients with paraneoplastic cerebellar ataxia.
    Miske R; Scharf M; Borowski K; Rieckhoff N; Teegen B; Denno Y; Probst C; Guthke K; Didrihsone I; Wildemann B; Ruprecht K; Komorowski L; Jarius S
    J Neuroinflammation; 2023 Mar; 20(1):88. PubMed ID: 36997937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-SEZ6L2 antibodies in paraneoplastic cerebellar syndrome: case report and review of the literature.
    Kather A; Holtbernd F; Brunkhorst R; Hasan D; Markewitz R; Wandinger KP; Wiesmann M; Schulz JB; Tauber SC
    Neurol Res Pract; 2022 Oct; 4(1):54. PubMed ID: 36310162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune Cerebellar Ataxia: Etiology and Clinical Characteristics of a Case Series from China.
    Liu M; Ren H; Zhu Y; Fan S; Bai L; Wang J; Cui L; Guan H
    Cerebellum; 2023 Jun; 22(3):379-385. PubMed ID: 35618871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraneoplastic autoimmune movement disorders.
    Lim TT
    Parkinsonism Relat Disord; 2017 Nov; 44():106-109. PubMed ID: 29097081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.